TVTX
insider transactionsTravere Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-691.1K
0 buy · 691.1K sell
Net value · 365d
-$25.0M
$0 in · $25.0M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
60
0 buy · 691.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Director · 10b5-1
$0
4.5K sh
Own New
-
Sell·S
Director · 10b5-1
$225.0K
4.5K sh · $50.00
Own -10%
-
Exercise·M
Director · 10b5-1
$96.2K
4.5K sh · $21.38
Own +11%
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
4.0K sh
Own +16%
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
4.0K sh
Own +11%
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
4.0K sh
Own +13%
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
4.0K sh
Own +11%
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
4.0K sh
Own +5%
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
4.0K sh
Own +11%
-
Grant·A
Director
$0
31.2K sh
Own New
-
Sell·S
Chief Research Officer · 10b5-1
$121.4K
2.8K sh · $43.95
Own -2%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$91.2K
2.1K sh · $43.95
Own -2%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$13.7K
311 sh · $43.95
Own -0%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$988.9K
22.5K sh · $43.95
Own -5%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$13.6K
310 sh · $43.95
Own -0%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$101.4K
2.2K sh · $46.65
Own -2%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$101.4K
2.2K sh · $46.65
Own -2%
-
Sell·S
CHIEF COMMERCIAL OFFICER
$101.4K
2.2K sh · $46.65
Own -2%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$101.7K
2.2K sh · $46.65
Own -2%
-
Exercise·M
Director · 10b5-1
$0
4.5K sh
Own New
-
Sell·S
Director · 10b5-1
$209.9K
4.5K sh · $46.65
Own -11%
-
Exercise·M
Director · 10b5-1
$82.2K
4.5K sh · $18.27
Own +12%
-
Exercise·M
Chief Research Officer · 10b5-1
$0
4.2K sh
Own New
-
Grant·A
Chief Research Officer · 10b5-1
$0
8.5K sh
Own New
-
Exercise·M
Chief Research Officer · 10b5-1
$0
4.2K sh
Own +4%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
4.2K sh
Own New
-
Grant·A
Chief Legal Officer and GC · 10b5-1
$0
8.5K sh
Own New
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
20.0K sh
Own New
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
4.2K sh
Own +4%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$900.0K
20.0K sh · $45.00
Own -16%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$359.2K
20.0K sh · $17.96
Own +19%
-
Exercise·M
Director · 10b5-1
$0
8.0K sh
Own New
-
Sell·S
Director · 10b5-1
$360.0K
8.0K sh · $45.00
Own -8%
-
Exercise·M
Director · 10b5-1
$130.6K
8.0K sh · $16.33
Own +9%
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$0
4.2K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER · 10b5-1
$0
8.5K sh
Own New
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$0
20.0K sh
Own +138%
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$0
4.2K sh
Own +4%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$900.0K
20.0K sh · $45.00
Own -15%
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$448.0K
20.0K sh · $22.40
Own +18%
-
Exercise·M
CHIEF COMMERCIAL OFFICER
$0
4.2K sh
Own New
-
Grant·A
CHIEF COMMERCIAL OFFICER
$0
8.5K sh
Own New
-
Exercise·M
CHIEF COMMERCIAL OFFICER
$0
4.2K sh
Own +3%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
22.5K sh
Own New
-
Grant·A
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
45.0K sh
Own New
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
22.5K sh
Own +5%
-
Exercise·M
CHIEF FINANCIAL OFFICER · 10b5-1
$0
4.2K sh
Own New
-
Grant·A
CHIEF FINANCIAL OFFICER · 10b5-1
$0
8.5K sh
Own New
-
Exercise·M
CHIEF FINANCIAL OFFICER · 10b5-1
$0
4.2K sh
Own +4%
-
Exercise·M
Director · 10b5-1
$0
9.8K sh
Own New
-
Sell·S
Director · 10b5-1
$431.1K
9.8K sh · $44.22
Own -21%
-
Exercise·M
Director · 10b5-1
$66.5K
9.8K sh · $6.82
Own +26%
-
Grant·A
Director
—
83 sh
Own +0%
-
Sell·S
Chief Research Officer · 10b5-1
$355.7K
9.1K sh · $39.09
Own -7%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$66.3K
1.6K sh · $42.53
Own -1%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$217.5K
5.2K sh · $41.62
Own -5%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$43.4K
1.0K sh · $42.61
Own -1%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$853
20 sh · $42.66
Own -0%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$299.1K
7.2K sh · $41.75
Own -2%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$2.3M
56.8K sh · $41.01
Own -11%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$43.2K
1.0K sh · $42.61
Own -1%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
20.0K sh
Own New
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
10.0K sh
Own New
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
7.5K sh
Own +25%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$302.5K
7.2K sh · $41.93
Own -6%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$1.5M
37.5K sh · $41.07
Own -24%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$116.0K
7.5K sh · $15.46
Own +5%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$359.2K
20.0K sh · $17.96
Own +15%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$190.8K
10.0K sh · $19.08
Own +8%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$302.5K
7.2K sh · $41.93
Own -6%
-
Sell·S
CHIEF COMMERCIAL OFFICER
$302.5K
7.2K sh · $41.93
Own -5%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$303.5K
7.2K sh · $41.93
Own -6%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$370
9 sh · $41.07
Own -0%
-
Exercise·M
SVP, CHIEF ACCOUNTING OFFICER · 10b5-1
$0
6.5K sh
Own +50%
-
Exercise·M
SVP, CHIEF ACCOUNTING OFFICER · 10b5-1
$0
6.2K sh
Own +100%
-
Exercise·M
SVP, CHIEF ACCOUNTING OFFICER · 10b5-1
$0
2.5K sh
Own +100%
-
Sell·S
SVP, CHIEF ACCOUNTING OFFICER · 10b5-1
$902.6K
22.0K sh · $41.07
Own -34%
-
Exercise·M
SVP, CHIEF ACCOUNTING OFFICER · 10b5-1
$133.0K
6.5K sh · $20.46
Own +11%
-
Exercise·M
SVP, CHIEF ACCOUNTING OFFICER · 10b5-1
$55.8K
6.2K sh · $8.93
Own +12%
-
Exercise·M
SVP, CHIEF ACCOUNTING OFFICER · 10b5-1
$56.0K
2.5K sh · $22.40
Own +5%
-
Exercise·M
Director · 10b5-1
$0
6.8K sh
Own New
-
Exercise·M
Director · 10b5-1
$0
4.5K sh
Own New
-
Exercise·M
Director · 10b5-1
$0
9.0K sh
Own New
-
Exercise·M
Director · 10b5-1
$0
8.0K sh
Own New
-
Sell·S
Director · 10b5-1
$284.3K
6.8K sh · $42.12
Own -15%
-
Sell·S
Director · 10b5-1
$1.1M
26.0K sh · $41.07
Own -37%
-
Exercise·M
Director · 10b5-1
$115.5K
6.8K sh · $17.11
Own +11%
-
Exercise·M
Director · 10b5-1
$96.2K
4.5K sh · $21.38
Own +8%
-
Exercise·M
Director · 10b5-1
$82.2K
4.5K sh · $18.27
Own +8%
-
Exercise·M
Director · 10b5-1
$138.9K
9.0K sh · $15.43
Own +20%
-
Exercise·M
Director · 10b5-1
$143.5K
8.0K sh · $17.94
Own +21%
-
Grant·A
Chief Research Officer · 10b5-1
$0
14.0K sh
Own +13%
-
Grant·A
Chief Legal Officer and GC · 10b5-1
$0
14.0K sh
Own +13%
-
Grant·A
CHIEF MEDICAL OFFICER · 10b5-1
$0
14.0K sh
Own +13%
-
Grant·A
CHIEF COMMERCIAL OFFICER
$0
14.0K sh
Own +11%
-
Grant·A
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
64.0K sh
Own +15%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$1.9K
65 sh · $28.85
Own -0%
-
Grant·A
CHIEF FINANCIAL OFFICER · 10b5-1
$0
14.0K sh
Own +13%
-
Exercise·M
Director · 10b5-1
$0
10.0K sh
Own New
-
Sell·S
Director · 10b5-1
$330.0K
10.0K sh · $33.00
Own -21%
-
Exercise·M
Director · 10b5-1
$265.2K
10.0K sh · $26.52
Own +27%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
10.0K sh
Own +29%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$300.0K
10.0K sh · $30.00
Own -9%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$154.6K
10.0K sh · $15.46
Own +10%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
60.0K sh
Own New
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$789.6K
25.1K sh · $31.46
Own -5%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$1.1M
34.9K sh · $30.55
Own -7%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$927.6K
60.0K sh · $15.46
Own +14%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
10.0K sh
Own New
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$280.9K
10.0K sh · $28.09
Own -9%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$190.8K
10.0K sh · $19.08
Own +10%
-
Grant·A
Chief Medical Officer
$0
134.1K sh
Own New
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
60.0K sh
Own New
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$1.8M
60.0K sh · $30.10
Own -12%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$927.6K
60.0K sh · $15.46
Own +14%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
10.0K sh
Own +100%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$122.1K
4.3K sh · $28.26
Own -4%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$156.2K
5.7K sh · $27.50
Own -5%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$190.8K
10.0K sh · $19.08
Own +10%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$16.7K
509 sh · $32.74
Own -0%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$79.7K
2.5K sh · $32.07
Own -2%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$7.6K
232 sh · $32.85
Own -0%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$49.7K
1.5K sh · $32.11
Own -1%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$3.6K
110 sh · $32.90
Own -0%
-
Sell·S
CHIEF FINANCIAL OFFICER · 10b5-1
$52.5K
1.6K sh · $32.14
Own -1%
-
Sell·S
Chief Research Officer · 10b5-1
$409.1K
12.4K sh · $32.87
Own -10%
-
Sell·S
Chief Legal Officer and GC
$230.5K
7.2K sh · $32.12
Own -6%
-
Sell·S
CHIEF MEDICAL OFFICER
$223.4K
7.0K sh · $32.12
Own -6%
-
Sell·S
CHIEF COMMERCIAL OFFICER
$234.8K
7.3K sh · $32.12
Own -5%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$1.1M
33.6K sh · $32.70
Own -7%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$2.1M
66.5K sh · $32.06
Own -12%
-
Sell·S
CHIEF FINANCIAL OFFICER
$232.6K
7.2K sh · $32.12
Own -6%
-
Sell·S
SVP, CHIEF ACCOUNTING OFFICER
$139.2K
4.3K sh · $32.12
Own -8%
-
Grant·A
Chief Research Officer · 10b5-1
$0
53.6K sh
Own New
-
Grant·A
Chief Research Officer · 10b5-1
$0
20.1K sh
Own +20%
-
Grant·A
Chief Legal Officer and GC
$0
67.0K sh
Own New
-
Grant·A
Chief Legal Officer and GC
$0
25.1K sh
Own +28%
-
Grant·A
CHIEF MEDICAL OFFICER
$0
75.0K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
28.1K sh
Own +33%
-
Grant·A
CHIEF COMMERCIAL OFFICER
$0
69.6K sh
Own New
-
Grant·A
CHIEF COMMERCIAL OFFICER
$0
26.1K sh
Own +23%
-
Grant·A
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
303.6K sh
Own New
-
Grant·A
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
113.8K sh
Own +27%
-
Grant·A
CHIEF FINANCIAL OFFICER
$0
75.0K sh
Own New
-
Grant·A
CHIEF FINANCIAL OFFICER
$0
28.1K sh
Own +31%
-
Grant·A
SVP, CHIEF ACCOUNTING OFFICER
$0
20.2K sh
Own New
-
Grant·A
SVP, CHIEF ACCOUNTING OFFICER
$0
15.2K sh
Own +40%
-
Grant·A
Director
—
70 sh
Own +0%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
51.9K sh
Own +76%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$1.6M
51.9K sh · $30.10
Own -11%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$801.8K
51.9K sh · $15.46
Own +12%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$0
8.1K sh
Own +5%
-
Sell·S
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$244.2K
8.1K sh · $30.01
Own -2%
-
Exercise·M
Eric M Dube KEY
CHIEF EXECUTIVE OFFICER · 10b5-1
$125.8K
8.1K sh · $15.46
Own +2%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$0
10.0K sh
Own +50%
-
Sell·S
Chief Legal Officer and GC · 10b5-1
$273.4K
10.0K sh · $27.34
Own -10%
-
Exercise·M
Chief Legal Officer and GC · 10b5-1
$190.8K
10.0K sh · $19.08
Own +11%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$16.8K
445 sh · $37.75
Own -1%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$81.6K
2.0K sh · $40.18
Own -2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 4.5K | $0 |
| Jun 12, 2026 | Roy D. Baynes 10b5-1 | Sell S | 4.5K | $225.0K |
| Jun 12, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 4.5K | $96.2K |
| May 19, 2026 | Brinkley Ruth Williams | Grant A | 12.0K | $0 |
| May 19, 2026 | Brinkley Ruth Williams | Grant A | 4.0K | $0 |
| May 19, 2026 | Ron Squarer | Grant A | 12.0K | $0 |
| May 19, 2026 | Ron Squarer | Grant A | 4.0K | $0 |
| May 19, 2026 | Sandra Poole | Grant A | 12.0K | $0 |
| May 19, 2026 | Sandra Poole | Grant A | 4.0K | $0 |
| May 19, 2026 | John A Orwin | Grant A | 12.0K | $0 |
| May 19, 2026 | John A Orwin | Grant A | 4.0K | $0 |
| May 19, 2026 | Jeffrey A Meckler | Grant A | 12.0K | $0 |
| May 19, 2026 | Jeffrey A Meckler | Grant A | 4.0K | $0 |
| May 19, 2026 | Roy D. Baynes | Grant A | 12.0K | $0 |
| May 19, 2026 | Roy D. Baynes | Grant A | 4.0K | $0 |
| May 15, 2026 | Roy D. Baynes | Grant A | 31.2K | $0 |
| May 6, 2026 | William E. Rote 10b5-1 | Sell S | 2.8K | $121.4K |
| May 6, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 2.1K | $91.2K |
| May 6, 2026 | Jula Inrig 10b5-1 | Sell S | 311 | $13.7K |
| May 6, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 22.5K | $988.9K |
| May 6, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 310 | $13.6K |
| May 5, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 2.2K | $101.4K |
| May 5, 2026 | Jula Inrig 10b5-1 | Sell S | 2.2K | $101.4K |
| May 5, 2026 | Peter Heerma | Sell S | 2.2K | $101.4K |
| May 5, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 2.2K | $101.7K |
| May 5, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 4.5K | $0 |
| May 5, 2026 | Roy D. Baynes 10b5-1 | Sell S | 4.5K | $209.9K |
| May 5, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 4.5K | $82.2K |
| May 4, 2026 | William E. Rote 10b5-1 | Exercise M | 4.2K | $0 |
| May 4, 2026 | William E. Rote 10b5-1 | Grant A | 8.5K | $0 |
| May 4, 2026 | William E. Rote 10b5-1 | Exercise M | 4.2K | $0 |
| May 4, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 4.2K | $0 |
| May 4, 2026 | Elizabeth E Reed 10b5-1 | Grant A | 8.5K | $0 |
| May 4, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 20.0K | $0 |
| May 4, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 4.2K | $0 |
| May 4, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 20.0K | $900.0K |
| May 4, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 20.0K | $359.2K |
| May 4, 2026 | Jeffrey A Meckler 10b5-1 | Exercise M | 8.0K | $0 |
| May 4, 2026 | Jeffrey A Meckler 10b5-1 | Sell S | 8.0K | $360.0K |
| May 4, 2026 | Jeffrey A Meckler 10b5-1 | Exercise M | 8.0K | $130.6K |
| May 4, 2026 | Jula Inrig 10b5-1 | Exercise M | 4.2K | $0 |
| May 4, 2026 | Jula Inrig 10b5-1 | Grant A | 8.5K | $0 |
| May 4, 2026 | Jula Inrig 10b5-1 | Exercise M | 20.0K | $0 |
| May 4, 2026 | Jula Inrig 10b5-1 | Exercise M | 4.2K | $0 |
| May 4, 2026 | Jula Inrig 10b5-1 | Sell S | 20.0K | $900.0K |
| May 4, 2026 | Jula Inrig 10b5-1 | Exercise M | 20.0K | $448.0K |
| May 4, 2026 | Peter Heerma | Exercise M | 4.2K | $0 |
| May 4, 2026 | Peter Heerma | Grant A | 8.5K | $0 |
| May 4, 2026 | Peter Heerma | Exercise M | 4.2K | $0 |
| May 4, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 22.5K | $0 |
| May 4, 2026 | Eric M Dube KEY 10b5-1 | Grant A | 45.0K | $0 |
| May 4, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 22.5K | $0 |
| May 4, 2026 | Christopher R. Cline KEY 10b5-1 | Exercise M | 4.2K | $0 |
| May 4, 2026 | Christopher R. Cline KEY 10b5-1 | Grant A | 8.5K | $0 |
| May 4, 2026 | Christopher R. Cline KEY 10b5-1 | Exercise M | 4.2K | $0 |
| May 1, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 9.8K | $0 |
| May 1, 2026 | Roy D. Baynes 10b5-1 | Sell S | 9.8K | $431.1K |
| May 1, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 9.8K | $66.5K |
| Apr 24, 2026 | Roy D. Baynes | Grant A | 83 | — |
| Apr 22, 2026 | William E. Rote 10b5-1 | Sell S | 9.1K | $355.7K |
| Apr 15, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 1.6K | $66.3K |
| Apr 15, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 5.2K | $217.5K |
| Apr 15, 2026 | Jula Inrig 10b5-1 | Sell S | 1.0K | $43.4K |
| Apr 15, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 20 | $853 |
| Apr 15, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 7.2K | $299.1K |
| Apr 15, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 56.8K | $2.3M |
| Apr 15, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 1.0K | $43.2K |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 20.0K | $0 |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $0 |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 7.5K | $0 |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 7.2K | $302.5K |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 37.5K | $1.5M |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 7.5K | $116.0K |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 20.0K | $359.2K |
| Apr 14, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $190.8K |
| Apr 14, 2026 | Jula Inrig 10b5-1 | Sell S | 7.2K | $302.5K |
| Apr 14, 2026 | Peter Heerma | Sell S | 7.2K | $302.5K |
| Apr 14, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 7.2K | $303.5K |
| Apr 14, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 9 | $370 |
| Apr 14, 2026 | Sandra Calvin 10b5-1 | Exercise M | 6.5K | $0 |
| Apr 14, 2026 | Sandra Calvin 10b5-1 | Exercise M | 6.2K | $0 |
| Apr 14, 2026 | Sandra Calvin 10b5-1 | Exercise M | 2.5K | $0 |
| Apr 14, 2026 | Sandra Calvin 10b5-1 | Sell S | 22.0K | $902.6K |
| Apr 14, 2026 | Sandra Calvin 10b5-1 | Exercise M | 6.5K | $133.0K |
| Apr 14, 2026 | Sandra Calvin 10b5-1 | Exercise M | 6.2K | $55.8K |
| Apr 14, 2026 | Sandra Calvin 10b5-1 | Exercise M | 2.5K | $56.0K |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 6.8K | $0 |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 4.5K | $0 |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 9.0K | $0 |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 8.0K | $0 |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Sell S | 6.8K | $284.3K |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Sell S | 26.0K | $1.1M |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 6.8K | $115.5K |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 4.5K | $96.2K |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 4.5K | $82.2K |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 9.0K | $138.9K |
| Apr 14, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 8.0K | $143.5K |
| Apr 13, 2026 | William E. Rote 10b5-1 | Grant A | 14.0K | $0 |
| Apr 13, 2026 | Elizabeth E Reed 10b5-1 | Grant A | 14.0K | $0 |
| Apr 13, 2026 | Jula Inrig 10b5-1 | Grant A | 14.0K | $0 |
| Apr 13, 2026 | Peter Heerma | Grant A | 14.0K | $0 |
| Apr 13, 2026 | Eric M Dube KEY 10b5-1 | Grant A | 64.0K | $0 |
| Apr 13, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 65 | $1.9K |
| Apr 13, 2026 | Christopher R. Cline KEY 10b5-1 | Grant A | 14.0K | $0 |
| Apr 6, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 10.0K | $0 |
| Apr 6, 2026 | Roy D. Baynes 10b5-1 | Sell S | 10.0K | $330.0K |
| Apr 6, 2026 | Roy D. Baynes 10b5-1 | Exercise M | 10.0K | $265.2K |
| Apr 1, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $0 |
| Apr 1, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 10.0K | $300.0K |
| Apr 1, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $154.6K |
| Apr 1, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 60.0K | $0 |
| Apr 1, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 25.1K | $789.6K |
| Apr 1, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 34.9K | $1.1M |
| Apr 1, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 60.0K | $927.6K |
| Mar 16, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $0 |
| Mar 16, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 10.0K | $280.9K |
| Mar 16, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $190.8K |
| Mar 2, 2026 | Roy D. Baynes | Grant A | 134.1K | $0 |
| Feb 20, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 60.0K | $0 |
| Feb 20, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 60.0K | $1.8M |
| Feb 20, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 60.0K | $927.6K |
| Feb 17, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $0 |
| Feb 17, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 4.3K | $122.1K |
| Feb 17, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 5.7K | $156.2K |
| Feb 17, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $190.8K |
| Feb 4, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 509 | $16.7K |
| Feb 4, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 2.5K | $79.7K |
| Feb 4, 2026 | Jula Inrig 10b5-1 | Sell S | 232 | $7.6K |
| Feb 4, 2026 | Jula Inrig 10b5-1 | Sell S | 1.5K | $49.7K |
| Feb 4, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 110 | $3.6K |
| Feb 4, 2026 | Christopher R. Cline KEY 10b5-1 | Sell S | 1.6K | $52.5K |
| Feb 3, 2026 | William E. Rote 10b5-1 | Sell S | 12.4K | $409.1K |
| Feb 3, 2026 | Elizabeth E Reed | Sell S | 7.2K | $230.5K |
| Feb 3, 2026 | Jula Inrig | Sell S | 7.0K | $223.4K |
| Feb 3, 2026 | Peter Heerma | Sell S | 7.3K | $234.8K |
| Feb 3, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 33.6K | $1.1M |
| Feb 3, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 66.5K | $2.1M |
| Feb 3, 2026 | Christopher R. Cline KEY | Sell S | 7.2K | $232.6K |
| Feb 3, 2026 | Sandra Calvin | Sell S | 4.3K | $139.2K |
| Jan 31, 2026 | William E. Rote 10b5-1 | Grant A | 53.6K | $0 |
| Jan 31, 2026 | William E. Rote 10b5-1 | Grant A | 20.1K | $0 |
| Jan 31, 2026 | Elizabeth E Reed | Grant A | 67.0K | $0 |
| Jan 31, 2026 | Elizabeth E Reed | Grant A | 25.1K | $0 |
| Jan 31, 2026 | Jula Inrig | Grant A | 75.0K | $0 |
| Jan 31, 2026 | Jula Inrig | Grant A | 28.1K | $0 |
| Jan 31, 2026 | Peter Heerma | Grant A | 69.6K | $0 |
| Jan 31, 2026 | Peter Heerma | Grant A | 26.1K | $0 |
| Jan 31, 2026 | Eric M Dube KEY 10b5-1 | Grant A | 303.6K | $0 |
| Jan 31, 2026 | Eric M Dube KEY 10b5-1 | Grant A | 113.8K | $0 |
| Jan 31, 2026 | Christopher R. Cline KEY | Grant A | 75.0K | $0 |
| Jan 31, 2026 | Christopher R. Cline KEY | Grant A | 28.1K | $0 |
| Jan 31, 2026 | Sandra Calvin | Grant A | 20.2K | $0 |
| Jan 31, 2026 | Sandra Calvin | Grant A | 15.2K | $0 |
| Jan 30, 2026 | Roy D. Baynes | Grant A | 70 | — |
| Jan 27, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 51.9K | $0 |
| Jan 27, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 51.9K | $1.6M |
| Jan 27, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 51.9K | $801.8K |
| Jan 23, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 8.1K | $0 |
| Jan 23, 2026 | Eric M Dube KEY 10b5-1 | Sell S | 8.1K | $244.2K |
| Jan 23, 2026 | Eric M Dube KEY 10b5-1 | Exercise M | 8.1K | $125.8K |
| Jan 20, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $0 |
| Jan 20, 2026 | Elizabeth E Reed 10b5-1 | Sell S | 10.0K | $273.4K |
| Jan 20, 2026 | Elizabeth E Reed 10b5-1 | Exercise M | 10.0K | $190.8K |
| Jan 6, 2026 | Jula Inrig 10b5-1 | Sell S | 445 | $16.8K |
| Jan 5, 2026 | Jula Inrig 10b5-1 | Sell S | 2.0K | $81.6K |
About TVTX insider trading
This page tracks insider transactions for Travere Therapeutics, Inc. (TVTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.